The International Society for Vaccines is an organization that engages, supports, and sustains the professional goals of a diverse membership in all areas relevant to vaccines - 2018 ISV Annual Congress

2018 President's Letter

Dr WeinerDear Colleagues, although we are in the midst of the holiday summer season, the ISV has been quite busing pursing society activities that we are excited to report. Looking first ahead to the fall and the ISV Congress, which has come together under the outstanding leadership of Denise L. Doolan and Ted M. Ross working with the scientific committee, will be held in Atlanta, USA, (October 28-30, 2018). An outstanding slew of leaders in high profile vaccine topics have been carefully collected to speak for this year’s meeting. As is the goal of the society, the invited speakers come from all over the globe and represent topics of high impact for the vaccine community. A detailed list of these outstanding speakers can be found on the ISV Congress web site (https://isvcongress.org/).

In addition, the review season for submitted abstracts to the congress has completed. There has been a very high volume of abstracts submitted with a global distribution which we are all thrilled about. The scientific committee had its work in hand reviewing these exciting submissions. As a reminder, late breaker submissions of high impact studies can be submitted for consideration, so please keep this in mind and plan to send in abstracts for this important session. As is ISV policy we support young and emerging scientists (graduate students and post-doctoral trainees) to attend and participate in the meeting through multiple programs. As envisioned by our past President, Dr. Margaret Liu, up to ten $500 awards will be offered to reimburse attendance costs based upon the evaluation of the abstracts by the scientific committee and final selection by the Congress Co-chairs and the ISV President. These can include authors of late breaker abstracts. These “Presidential” abstracts will be recognized at a special session of the ISV Congress. We continue the tradition of providing an award named in honor of Dr. Maurice Hilleman to the lead author of the most outstanding submitted abstract at the ISV annual congress as well as an award named in honor of Dr. Richard Ginsberg to the lead author of the best abstract from a trainee-submitted abstract. Through our continuing partnership with Vaccine Renaissance, selected scholarships for Women and Minority Delegates are available on an application-based selective basis. The details for all awards are updated on the ISV Congress site and covered in future issues of the bimonthly ISV Newsletter. Also, it’s important to keep in mind that the early bird deadline for registration for the congress is approaching (August 15, 2018) please go to the 2018 Congress website at https://isvcongress.org/ to place your registration.

Continue Reading

Julius S. Youngner, Sc.D., Polio Vaccine Pioneer and 2015 ISV Fellow, Dies at 96 years of age.

Julius S. Youngner, Sc.D., a world-renowned virologist best known for his contributions to the development of the first effective polio vaccine alongside Jonas Salk, died peacefully Thursday, April 27, 2017 at his home in Pittsburgh, surrounded by family.  Dr. Youngner, a Distinguished Service Professor Emeritus of microbiology and medical genetics at the University of Pittsburgh School of Medicine, had a remarkable scientific career that spanned more than 60 years, influenced the careers of an entire generation of virologists, and has saved innumerable lives. More info here.

Don't miss this interdisciplinary conference on the 1918 influenza pandemic: http://bit.ly/Flu1918Ypres

Historians and biomedical researchers will meet in Ypres (Belgium) on 7-8 February to discuss that dreadful event. Talks by Peter Piot, Laura Spinney, Jeffrey Reznick and Heidi Larson among many others.

This Friday (12/14) is the early bird deadline: registration cost is 50/75 euro for a wonderful program!